Yu Asano

Effect of interferon-based and -free therapy on early occurrence and recurrence of hepatocellular carcinoma in chronic hepatitis C

Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina et al. · Journal of Hepatology · 2017 · 209 citations

Medicine, Oncology, Hepatology +9

L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis

Hiroyuki Nakanishi, Masayuki Kurosaki, Kaoru Tsuchiya et al. · Clinical Gastroenterology and Hepatology · 2014 · 76 citations

Medicine, Pharmacology, Pharmacotherapy +6

Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapy

Hiroko Nagata, Mina Nakagawa, Yuki Nishimura‐Sakurai et al. · Hepatology International · 2016 · 62 citations

Medicine, Pathology, Hepatology +14

Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus

Shun Kaneko, Sei Kakinuma, Yasuhiro Asahina et al. · Scientific Reports · 2016 · 50 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +14

Naturally occurring, resistance‐associated hepatitis C virus NS5A variants are linked to interleukin‐28B genotype and are sensitive to interferon‐based therapy

Jun Itakura, Masayuki Kurosaki, Hitomi Takada et al. · Hepatology Research · 2015 · 38 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17